Research/002
The Investigation Gap: Why 48% of FDA Warning Letters Cite the Same Problem
Nearly half of FDA warning letters to pharmaceutical and medical device manufacturers cite inadequate root cause investigation. The problem lies in diagnosis rather than detection.
Access Post →
